An underground market for unapproved weight-loss medications is being driven by social media fitness personalities and sellers on messaging platforms, according to recent findings.
Investigational Drug Gaining Popularity Online
Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its alleged weight-reducing effects. Viewers are urged to contact these accounts privately for supplier links, while also receiving discount codes.
Thriving Commerce on Messaging Platforms
Separately, a robust trade exists on Telegram, where communities with numerous of participants share comparison photos, injection guides and assertions of rapid UK delivery. Vendors promote the substance there before directing buyers to other platforms for purchases.
Understanding The Experimental Drug
Retatrutide is an investigational injection created by US drugmaker Eli Lilly. The treatment affects three gut hormones – GLP-1, GIP and glucagon. Early trials indicate it could help individuals reduce up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being hailed digitally as the next Ozempic.
Medical Experts Express Concerns
However, physicians and chemists have warned that the distribution of what remains an unapproved drug in the UK is worrisome and could lead to individuals injecting products of unknown origin.
Some experts said the popularity for retatrutide could be linked to the increasing cost of licensed weight loss treatments such as Mounjaro.
Regulatory Status and Enforcement
Selling the unapproved drug on social media or messaging apps is illegal in the United Kingdom, as it is an unapproved drug that must not be marketed or distributed for human use under the British medical regulations.
Some content creators attempt to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but promotion and distribution can still violate pharmaceutical, advertising, and customer regulations, risking fines, legal action or imprisonment.
Platform Reaction and Material Removal
According to TikTok, the service has removed problematic material and prohibited related keywords and search suggestions. The organization said it was committed to keeping the platform secure and allocating resources in strengthening compliance measures.
Digital Marketplace Activities
Research also discovered groups with up to 9,000 members selling retatrutide using the platform's built-in discovery tool, which operates like a public directory. Entering “retatrutide” immediately brings up groups with thousands of users, populated with images of weight loss, positive reviews and detailed instructions for mixing or administering at home.
After moments of joining one group, a vendor shared WhatsApp details, where the majority of transactions take place. The seller sent an instruction manual and guaranteed delivery within two days. When questioned whether the product was genuine, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. None asked about weight, health issues or past usage.
Item Details and Costs
Within these communities, messages show black plastic parcels with postal service stickers, stating to include new batches. One communication stated: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, prepared at residence with purified liquid, or pre-filled pens usually priced at £160 for 20mg. When questioned how long a pen should be used, sellers give conflicting responses varying between a few weeks to “depends on your body”.
Platform Moderation and Safety Actions
A representative for the messaging service said it regularly monitored dangerous material on its service including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“People are administering substances they cannot confirm. Although the research behind this drug is valid, these online versions may not include what they claim,” stated Jason Murphy, the director of pharmacy at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to recent cost increases for authorized slimming drugs such as Mounjaro. “With prices increasing, patients are turning to online platforms. But fake treatments are highly risky. You cannot know what’s inside or whether the environment they were made in was sterile,” she said.
Her team has previously encountered patients injured by self-injection from unconfirmed suppliers. “We understand the disappointment, but buying from Telegram or communication platforms is taking chances with your well-being,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”
Manufacturer Statement
A spokesperson from Eli Lilly stated the substance was in phase 3 research studies and had not been evaluated or authorized by any government authority globally. “Consequently at this time no one can sell [it] for human use,” they said, adding that any item “falsely representing itself as a company investigational substance not yet approved … may expose patients to possibly significant health risks”.
